KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,963,635 | -72.2% | 35,269 | -64.3% | 0.00% | -75.0% |
| Q2 2023 | $21,447,332 | -28.9% | 98,904 | -40.5% | 0.00% | -33.3% |
| Q1 2023 | $30,174,582 | -20.3% | 166,123 | -13.7% | 0.01% | -25.0% |
| Q4 2022 | $37,837,451 | +7.7% | 192,557 | +23.2% | 0.01% | 0.0% |
| Q3 2022 | $35,144,000 | +48.7% | 156,246 | -16.4% | 0.01% | +60.0% |
| Q2 2022 | $23,642,000 | +22.7% | 186,877 | +23.0% | 0.01% | +25.0% |
| Q1 2022 | $19,267,000 | -18.9% | 151,955 | -16.2% | 0.00% | 0.0% |
| Q4 2021 | $23,745,000 | +6.7% | 181,263 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $22,252,000 | +5.6% | 181,898 | -1.6% | 0.00% | 0.0% |
| Q2 2021 | $21,074,000 | +9.9% | 184,875 | +16.0% | 0.00% | -20.0% |
| Q1 2021 | $19,168,000 | +30.6% | 159,434 | +10.3% | 0.01% | +25.0% |
| Q4 2020 | $14,682,000 | +106.6% | 144,516 | +57.2% | 0.00% | +100.0% |
| Q3 2020 | $7,108,000 | +83.8% | 91,925 | +164.9% | 0.00% | +100.0% |
| Q2 2020 | $3,868,000 | +230.6% | 34,703 | +113.6% | 0.00% | – |
| Q1 2020 | $1,170,000 | -1.8% | 16,244 | +2.8% | 0.00% | – |
| Q4 2019 | $1,191,000 | -22.2% | 15,809 | -79.3% | 0.00% | – |
| Q2 2019 | $1,531,000 | – | 76,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |